Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dl-cycloserine
2. 68-39-3
3. 4-amino-1,2-oxazolidin-3-one
4. 4-amino-3-isoxazolidinone
5. Dl-4-aminoisoxazolidin-3-one
6. 3-isoxazolidinone, 4-amino-
7. Rac Cycloserine
8. 4-amino-3-isoxazolidone
9. Dl-4-amino-3-isoxazolidinone
10. Nsc154851
11. 3-isoxazolidinone, D-
12. 4-amino-4,5-dihydro-1,2-oxazol-3-ol
13. 3-isoxazolidinone, (r)-
14. 3-isoxazolidinone, (+)-
15. Wln: T5omvj Dz -d
16. Cycloserine, D-
17. .alpha.-cycloserine
18. (+-)-4-amino-3-isoxazolidinone
19. (+-)-oxamicina [italian]
20. (+-)-oxamicina
21. Einecs 200-687-9
22. (+-)-4-amino-3-isossazolidone [italian]
23. Ai3-61058
24. Mfcd00005353
25. (+-)-4-amino-3-isossazolidone
26. 3-isoxazolidinone, 4-amino-, (+-)-
27. Mfcd00064323
28. 3-isoxazolidinone,4-amino-, (4r)-
29. 4-amino-isoxazolidin-3-on
30. Dl-cycloserine, Crystalline
31. 4-amino-isoxazolidin-3-one
32. Lopac0_000267
33. Schembl34323
34. 4-amino-2-isoxazoline-3-ol
35. 4-amino-3-isoxazolidinone #
36. Chebi:23503
37. Dtxsid40859074
38. Hms3260f16
39. Hms3370d10
40. Hms3374e09
41. Hms3393c15
42. Pharmakon1600-01506178
43. Act10891
44. Bcp22967
45. Bcp22968
46. Nsc76029
47. Tox21_500267
48. (+/-)-3-oxoisooxazolidin-4-amine
49. Bbl016489
50. Nsc760409
51. Stk177281
52. Stl454326
53. Akos005410669
54. Ccg-204362
55. Cs-w008440
56. Lp00267
57. Sb23044
58. Sdccgsbi-0050255.p002
59. Ncgc00015213-04
60. Ncgc00015213-05
61. Ncgc00015213-06
62. Ncgc00015213-07
63. Ncgc00015213-08
64. Ncgc00015213-11
65. Ncgc00093725-01
66. Ncgc00093725-02
67. Ncgc00093725-03
68. Ncgc00093725-04
69. Ncgc00260952-01
70. Bp-20174
71. Ds-18396
72. Sy005636
73. Db-055147
74. Db-055151
75. Db-068913
76. Am20100628
77. Eu-0100267
78. Ft-0624464
79. Ft-0631297
80. Ft-0665409
81. Ft-0696808
82. O-isobutyl (3,4-dichlorophenyl)carbamothioate
83. C 7005
84. C06682
85. 064c323
86. A855990
87. A858006
88. Sr-01000075776
89. Sr-01000075776-1
90. W-104673
91. Q27109800
92. Cycloserine; Seromycin; Orientomycin; Oxamycin; Seromycin
93. (s)-4-amino-3-isoxazolidone; (s)-cycloserine;levcycloserine
| Molecular Weight | 102.09 g/mol |
|---|---|
| Molecular Formula | C3H6N2O2 |
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 102.042927438 g/mol |
| Monoisotopic Mass | 102.042927438 g/mol |
| Topological Polar Surface Area | 64.4 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 92.9 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
30
PharmaCompass offers a list of Dl-Cycloserine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dl-Cycloserine manufacturer or Dl-Cycloserine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dl-Cycloserine manufacturer or Dl-Cycloserine supplier.
PharmaCompass also assists you with knowing the Dl-Cycloserine API Price utilized in the formulation of products. Dl-Cycloserine API Price is not always fixed or binding as the Dl-Cycloserine Price is obtained through a variety of data sources. The Dl-Cycloserine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 064C323 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 064C323, including repackagers and relabelers. The FDA regulates 064C323 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 064C323 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 064C323 supplier is an individual or a company that provides 064C323 active pharmaceutical ingredient (API) or 064C323 finished formulations upon request. The 064C323 suppliers may include 064C323 API manufacturers, exporters, distributors and traders.
064C323 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 064C323 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 064C323 GMP manufacturer or 064C323 GMP API supplier for your needs.
A 064C323 CoA (Certificate of Analysis) is a formal document that attests to 064C323's compliance with 064C323 specifications and serves as a tool for batch-level quality control.
064C323 CoA mostly includes findings from lab analyses of a specific batch. For each 064C323 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
064C323 may be tested according to a variety of international standards, such as European Pharmacopoeia (064C323 EP), 064C323 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (064C323 USP).
